Semler Scientific (OTCMKTS:SMLR) issued its quarterly earnings results on Sunday. The medical equipment provider reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.11, MarketWatch Earnings reports. Semler Scientific had a net margin of 32.08% and a return on equity of 67.38%.
SMLR stock traded up $3.00 on Tuesday, hitting $115.00. 13,186 shares of the company’s stock traded hands, compared to its average volume of 18,015. The stock has a market cap of $772.46 million, a price-to-earnings ratio of 78.87, a P/E/G ratio of 1.48 and a beta of 1.11. Semler Scientific has a 1-year low of $39.22 and a 1-year high of $118.97. The stock has a fifty day moving average of $109.23 and a 200-day moving average of $91.17.
A number of equities research analysts have weighed in on the company. B. Riley upped their target price on Semler Scientific from $147.00 to $151.00 and gave the stock a “buy” rating in a research report on Tuesday. Zacks Investment Research raised Semler Scientific from a “hold” rating to a “buy” rating and set a $115.00 target price for the company in a research note on Saturday, February 27th.
Semler Scientific Company Profile
Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Recommended Story: Earnings Reports
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.